We hypothesize that the internalization of HER2 after aptamer binding may be involved in this growth retardation, because internalization of receptors results in both short and long term loss of receptor activity and because HER2-overexpressing cancer cells are highly dependent on HER2 signaling for survival and proliferation [88,89,90,91]. The gene discussed is ERBB2; the disease is cancer.